We are live on ! Find out more
TCP

Tourbillon Capital Partners Portfolio holdings

AUM $6.26M
1-Year Est. Return 42.29%
This Fund
S&P 500
This Quarter Est. Return
+19.55%
1 Year Est. Return
-42.29%
3 Year Est. Return
-18.38%
5 Year Est. Return
+32.21%
10 Year Est. Return
–
AUM
$4.9B
AUM Growth
-$102M
Cap. Flow
-$507M
Cap. Flow %
-10.35%
Top 10 Hldgs %
45.14%
Holding
91
New
32
Increased
18
Reduced
10
Closed
23

Top Buys

Rank Stock Value
1
LDOS icon
Leidos
LDOS
+$126M
2
AAPL icon
Apple
AAPL
+$95.3M
3
VTRS icon
Viatris
VTRS
+$58.2M
4
SRPT icon
Sarepta Therapeutics
SRPT
+$51.8M
5
SCHW
Charles Schwab
SCHW
+$51.3M

Top Sells

Rank Stock Value
1
T icon
AT&T
T
+$300M
2
MDVN
MEDIVATION, INC.
MDVN
+$285M
3
EXPE icon
Expedia Group
EXPE
+$138M
4
CTXS
Citrix Systems Inc
CTXS
+$94.7M
5
SPB icon
Spectrum Brands
SPB
+$51.4M

Sector Composition

Rank Sector Weight
1 Technology 14.73%
2 Consumer Discretionary 9.56%
3 Consumer Staples 7.66%
4 Healthcare 6.78%
5 Communication Services 6.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SPB icon
51
CALL
Spectrum Brands
SPB
$2.04B
$20.6M 0.42%
149,500
+99,800
+201% +$12.7M
CPN
52
CALL
DELISTED
Calpine Corporation
CPN
$20.5M 0.42%
+1,625,000
New +$21.9M
GWPH
53
PUT
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$19.9M 0.41%
+150,000
New +$14.3M
NRG icon
54
CALL
NRG Energy
NRG
$29.2B
$19.4M 0.4%
+1,727,000
New +$22.5M
SRPT icon
55
CALL
Sarepta Therapeutics
SRPT
$1.68B
$18.4M 0.38%
+300,000
New +$9.07M
CTSH icon
56
CALL
Cognizant
CTSH
$24.9B
$14.3M 0.29%
+300,000
New +$17.1M
RDUS
57
PUT
DELISTED
Radius Health, Inc.
RDUS
$14.3M 0.29%
+264,000
New +$13.4M
TEVA icon
58
Teva Pharmaceuticals
TEVA
$40.2B
$13.3M 0.27%
+290,000
New +$15.1M
GIS icon
59
PUT
General Mills
GIS
$19.2B
$12.8M 0.26%
+200,000
New +$13.9M
DYN
60
CALL
DELISTED
Dynegy, Inc.
DYN
$12.4M 0.25%
+1,000,000
New +$14.2M
VSAT icon
61
Viasat
VSAT
$11.2B
$9.34M 0.19%
125,095
– –
MIC
62
DELISTED
Macquarie Infrastructure Holdings, LLC
MIC
$9.02M 0.18%
108,324
-53,538
-33% -$4.25M
JAZZ icon
63
Jazz Pharmaceuticals
JAZZ
$15.8B
$8.02M 0.16%
+66,000
New +$8.9M
IMMU
64
DELISTED
Immunomedics Inc
IMMU
$7.8M 0.16%
2,400,000
– –
ACHN
65
DELISTED
Achillion Pharmaceuticals
ACHN
$7.5M 0.15%
+926,326
New +$7.88M
SCTL
66
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
$5.72M 0.12%
720,905
– –
IMMU
67
CALL
DELISTED
Immunomedics Inc
IMMU
$4.88M 0.1%
1,500,000
– –
PLXP
68
DELISTED
PLx Pharma Inc. Common Stock
PLXP
$3.45M 0.07%
29,734
– –
BABA icon
69
Alibaba
BABA
$305B
– –
-515,000
Closed -$41M
BHC icon
70
CALL
Bausch Health
BHC
$2.62B
– –
-400,000
Closed -$8.06M
CCEP icon
71
CALL
Coca-Cola Europacific Partners
CCEP
$47.8B
– –
-1,000,000
Closed -$35.7M
EEM icon
72
CALL
iShares MSCI Emerging Markets ETF
EEM
$28.9B
– –
-2,000,000
Closed -$68.7M
GEN icon
73
CALL
Gen Digital
GEN
$16.9B
– –
-1,000,000
Closed -$20.5M
GS icon
74
CALL
Goldman Sachs
GS
$303B
– –
-200,000
Closed -$29.7M
HRI icon
75
Herc Holdings
HRI
$5.48B
– –
-1,100,000
Closed -$36.5M
1 2
3
4

Similar funds

BC
Blueport Capital Fort Worth, Texas $5.8M AUM 4.95% 1-Year Est. Return
LBG
Lloyds Banking Group London, United Kingdom $7.15M AUM 0.75% 1-Year Est. Return
TGA
Trilogy Global Advisors Winter Park, Florida $712K AUM 8.54% 1-Year Est. Return
ACM
Archer Capital Management New York $16.2M AUM 17.01% 1-Year Est. Return
MGFS
Miller Green Financial Services Spring, Texas $17.6M AUM
LA
Lexington Advisors New York $18.7M AUM 48.36% 1-Year Est. Return
CT
CMT Trading Chicago, Illinois $22.4M AUM 78.15% 1-Year Est. Return
NMM
NGP MR Management Dallas, Texas $23.4M AUM 15.8% 1-Year Est. Return

Tourbillon Capital Partners's Q3 2016 Portfolio in Review

As of Q3 2016, Tourbillon Capital Partners held 91 positions worth $4.9B, down 2% from $5B the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Tourbillon Capital Partners withdrew a net $507M in Q3 2016, closing 23 positions and reducing 10 holdings. Its most notable exit was AT&T, an estimated $300M position sold in full.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 9.8% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.

Against the trend, Tourbillon Capital Partners opened a new position in Leidos worth $120M.

  • Tourbillon Capital Partners's largest Q3 2016 buy was Leidos: 2,775,000 shares worth $120M.
  • Tourbillon Capital Partners added most to Trip.com Group in Q3 2016, an estimated $37.2M increase.
  • Tourbillon Capital Partners's biggest Q3 2016 reduction was Expedia Group, cutting an estimated $138M.
  • Tourbillon Capital Partners fully exited AT&T in Q3 2016, selling an estimated $300M.
  • Tourbillon Capital Partners's ten largest holdings make up 45% of its $4.9B portfolio in Q3 2016.
  • Tourbillon Capital Partners opened 32 new positions and closed 23 in Q3 2016.
  • Tourbillon Capital Partners's portfolio value fell 2% quarter-over-quarter to $4.9B.

Based on Tourbillon Capital Partners's 13F filing for Q3 2016, filed 14 Nov 2016.